New drug EA5 passes first safety check in healthy people
NCT ID NCT07256288
First seen Jan 04, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This early-stage study tested a single dose of EA5 in 28 healthy adults to see if it is safe and how the body processes it. Participants received either EA5 or a placebo, and researchers monitored side effects and drug levels in the blood. This trial does not aim to treat any disease; it is a first step to gather safety information before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230601, China
Conditions
Explore the condition pages connected to this study.